Cutera, Inc. (NASDAQ:CUTR) EVP Miguel Pardos sold 5,000 shares of the company’s stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $36.00, for a total transaction of $180,000.00. Following the sale, the executive vice president now directly owns 39,698 shares of the company’s stock, valued at approximately $1,429,128. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Cutera, Inc. (NASDAQ CUTR) traded up 3.50% during midday trading on Friday, hitting $38.45. 150,149 shares of the stock were exchanged. The firm has a 50-day moving average price of $30.86 and a 200-day moving average price of $24.14. The stock has a market cap of $538.49 million, a P/E ratio of 82.69 and a beta of 0.60. Cutera, Inc. has a one year low of $10.54 and a one year high of $38.60.

Cutera (NASDAQ:CUTR) last posted its quarterly earnings data on Monday, August 7th. The medical device company reported $0.13 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.10. The firm had revenue of $36.40 million during the quarter, compared to analysts’ expectations of $32.08 million. Cutera had a return on equity of 11.64% and a net margin of 5.07%. The firm’s quarterly revenue was up 32.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.07 EPS. On average, equities research analysts anticipate that Cutera, Inc. will post $0.52 EPS for the current fiscal year.

Cutera announced that its board has approved a stock repurchase plan on Monday, August 7th that allows the company to repurchase $25.00 million in shares. This repurchase authorization allows the medical device company to reacquire up to 6.8% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

TRADEMARK VIOLATION WARNING: “Cutera, Inc. (CUTR) EVP Sells $180,000.00 in Stock” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at

A number of research firms have recently issued reports on CUTR. BidaskClub raised shares of Cutera from a “hold” rating to a “buy” rating in a report on Saturday, August 12th. TheStreet raised shares of Cutera from a “c” rating to a “b” rating in a report on Friday, August 18th. Gabelli reaffirmed a “buy” rating on shares of Cutera in a report on Wednesday, August 9th. Maxim Group reaffirmed a “buy” rating and set a $33.00 target price (up previously from $27.00) on shares of Cutera in a report on Thursday, July 13th. Finally, Roth Capital upped their target price on shares of Cutera from $32.00 to $39.00 and gave the stock a “buy” rating in a report on Tuesday, August 8th. Six analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and an average price target of $33.25.

A number of hedge funds have recently bought and sold shares of the stock. Kennedy Capital Management Inc. acquired a new stake in Cutera during the second quarter valued at approximately $9,426,000. Stonepine Capital Management LLC purchased a new position in Cutera during the second quarter valued at $4,533,000. Renaissance Technologies LLC raised its position in Cutera by 13.4% in the first quarter. Renaissance Technologies LLC now owns 1,205,400 shares of the medical device company’s stock valued at $24,952,000 after buying an additional 142,140 shares in the last quarter. Summit Creek Advisors LLC purchased a new position in Cutera during the second quarter valued at $3,380,000. Finally, Ameriprise Financial Inc. purchased a new position in Cutera during the second quarter valued at $3,175,000. Institutional investors own 89.15% of the company’s stock.

Cutera Company Profile

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with's FREE daily email newsletter.